Uptake of varicella vaccine - A cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation

被引:33
作者
Marshall, H
Ryan, P
Roberton, D
机构
[1] Womens & Childrens Hosp, Dept Paediat, Adelaide, SA 5006, Australia
[2] Univ Adelaide, Dept Publ Hlth, Adelaide, SA, Australia
[3] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia
关键词
varicella; vaccine uptake; parental attitudes;
D O I
10.1016/j.vaccine.2005.05.033
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of this study was to assess the uptake of varicella vaccine in South Australian children under circumstances where varicella immunisation is recommended, but is not funded by Government. The study examined the main reasons that determined a parent's decision whether or not to have their child immunised with varicella vaccine. A cross-sectional survey was conducted by Computer Aided Telephone Interviews (CATI) in June 2004. Data were obtained from 613 households containing 1148 children aged from birth to 17 years of age. Statistical analyses were performed using data weighted to the South Australian population. Six hundred and eighty children (55.7%) had a history of varicella infection and 446 children (42.0%) had received varicella vaccine (weighted data). The most common reasons cited for not having children immunised included lack of knowledge about the vaccine and cost. One year after inclusion of varicella vaccine in the Australian Standard Vaccination Schedule there is evidence of incomplete coverage in children in South Australia due to absence of government funding for vaccine provision. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5389 / 5397
页数:9
相关论文
共 31 条
[1]  
*AM AC PED, 2000 RED BOOK REP CO
[2]  
Atkinson W, 2002, VARICELLA EPIDEMIOLO
[3]   The cost-effectiveness of routine childhood varicella vaccination in Germany [J].
Banz, K ;
Wagenpfeil, S ;
Neiss, A ;
Goertz, A ;
Staginnus, U ;
Vollmar, J ;
Wutzler, P .
VACCINE, 2003, 21 (11-12) :1256-1267
[4]   Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes [J].
Brisson, M ;
Edmunds, WJ ;
Gay, NJ ;
Law, B ;
De Serres, G .
VACCINE, 2000, 18 (25) :2775-2778
[5]  
*CENS POP HOUS, 2001, SOC IND AR 2001
[6]   Varicella-zoster virus infection in Australia [J].
Chant, KG ;
Sullivan, EA ;
Burgess, MA ;
Ferson, MJ ;
Forrest, JM ;
Baird, LM ;
Tudehope, DI ;
Tilse, M .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 1998, 22 (04) :413-418
[7]   The incidence of shingles and its implications for vaccination policy [J].
Chapman, RS ;
Cross, KW ;
Fleming, DM .
VACCINE, 2003, 21 (19-20) :2541-2547
[8]   OVER 5-YEAR FOLLOW-UP OF OKA/MERCK VARICELLA VACCINE RECIPIENTS IN 465 INFANTS AND ADOLESCENTS [J].
CLEMENTS, DA ;
ARMSTRONG, CB ;
URSANO, AM ;
MOGGIO, MM ;
WALTER, EB ;
WILFERT, CM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (10) :874-879
[9]   Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States [J].
Davis, MM ;
Patel, MS ;
Gebremariam, A .
PEDIATRICS, 2004, 114 (03) :786-792
[10]   The effect of vaccination on the epidemiology of varicella zoster virus [J].
Edmunds, WJ ;
Brisson, M .
JOURNAL OF INFECTION, 2002, 44 (04) :211-219